Novel ddPCR assay precisely measures CAR T-cells after infusionFebruary 22, 2021DLBCLFollicular LymphomaB Cell Lymphoma
CAR T-cell products shine in real-world setting, reveal new insightsFebruary 18, 2021DLBCLB Cell Lymphoma
Chronic GVHD therapies offer hope for treating refractory diseaseFebruary 17, 2021DLBCLB Cell Lymphoma
Prognostic gene signature identifies high- vs. low-risk DLBCL patientsFebruary 17, 2021B Cell LymphomaDLBCL
Four-item prognostic index predicts survival in adult Burkitt lymphomaDecember 16, 2020B Cell Lymphoma
Synthetic lethality: Triple combination is a viable strategy for B-cell malignanciesDecember 11, 2020B Cell LymphomaDLBCLCLL
ZUMA-12 study shows frontline axi-cel has substantial activity in high-risk large B-cell lymphomaDecember 11, 2020B Cell Lymphoma
Pediatric regimens better for adolescents/young adults with aggressive B-cell NHLDecember 10, 2020B Cell Lymphoma
Bispecific antibody odronextamab demonstrates durable complete responses in refractory NHLDecember 10, 2020B Cell LymphomaDLBCL
COVID-19–related outcomes poor for patients with hematologic disease in ASH registryDecember 5, 2020B Cell Lymphoma
